Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)

Completed · Phase 2 · Has a placebo group

Conditions studied: Persian Gulf Syndrome

In brief

The purpose of this study is to perform a randomized double-blind, placebo-controlled, 12 week study of the effects of carnosine on cognitive, psychometric, autonomic, and muscle strength outcomes in 100 GWI subjects.

Key facts

Study ID

NCT00810368

Run by

Georgetown University

People needed

33

Starts

2008-08-01

Expected to finish

2012-07-01

Last updated by the study team

2019-06-28

Who can join

Age: 34 and older, up to 82. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Evidence of military enlistment between August 1, 1990 and July 31, 1991, and deployment for 30 consecutive days to:
• Persian Gulf waters and adjacent land areas,
• Other global locations, or,
• U.S. only. 1990-1991 enlistment status:
• Active duty
• National Guard
• Reserves

You may not qualify if…

• HIV/AIDS
• Pregnant Women
• Active Duty Military Personnel
• Children
• Incarceration

Where it is running

• Georgetown University — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.